Ying X - Search Results

1

Alteration in glycolytic/cholesterogenic gene expression is associated with bladder cancer prognosis and immune cell infiltration.

Zhang Y, Zhu B, Cai Y, Zhu S, Zhao H, Ying X, Jiang C, Zeng J. Zhang Y, et al. Among authors: ying x. BMC Cancer. 2022 Jan 3;22(1):2. doi: 10.1186/s12885-021-09064-0. BMC Cancer. 2022. PMID: 34980012 Free PMC article.

2

N6-Methylandenosine-Related lncRNAs Predict Prognosis and Immunotherapy Response in Bladder Cancer.

Zhang Y, Zhu B, He M, Cai Y, Ying X, Jiang C, Ji W, Zeng J. Zhang Y, et al. Among authors: ying x. Front Oncol. 2021 Aug 11;11:710767. doi: 10.3389/fonc.2021.710767. eCollection 2021. Front Oncol. 2021. PMID: 34458149 Free PMC article.

3

Programmable N6-methyladenosine modification of CDCP1 mRNA by RCas9-methyltransferase like 3 conjugates promotes bladder cancer development.

Ying X, Jiang X, Zhang H, Liu B, Huang Y, Zhu X, Qi D, Yuan G, Luo J, Ji W. Ying X, et al. Mol Cancer. 2020 Dec 3;19(1):169. doi: 10.1186/s12943-020-01289-0. Mol Cancer. 2020. PMID: 33267838 Free PMC article.

4

METTL1-m⁷ G-EGFR/EFEMP1 axis promotes the bladder cancer development.

Ying X, Liu B, Yuan Z, Huang Y, Chen C, Jiang X, Zhang H, Qi D, Yang S, Lin S, Luo J, Ji W. Ying X, et al. Clin Transl Med. 2021 Dec;11(12):e675. doi: 10.1002/ctm2.675. Clin Transl Med. 2021. PMID: 34936728 Free PMC article.

5

NXPH4 Used as a New Prognostic and Immunotherapeutic Marker for Muscle-Invasive Bladder Cancer.

Gui Z, Ying X, Liu C. Gui Z, et al. Among authors: ying x. J Oncol. 2022 Oct 4;2022:4271409. doi: 10.1155/2022/4271409. eCollection 2022. J Oncol. 2022. PMID: 36245981 Free PMC article.

6

Targeted m⁶A demethylation of ITGA6 mRNA by a multisite dCasRx-m⁶A editor inhibits bladder cancer development.

Ying X, Huang Y, Liu B, Hu W, Ji D, Chen C, Zhang H, Liang Y, Lv Y, Ji W. Ying X, et al. J Adv Res. 2024 Feb;56:57-68. doi: 10.1016/j.jare.2023.03.010. Epub 2023 Mar 30. J Adv Res. 2024. PMID: 37003532 Free PMC article.

7

Circular RNA LMBR1 inhibits bladder cancer progression by enhancing expression of the protein ALDH1A3.

Lv Y, Yuan Z, Chen D, Chen Z, Zhu X, Ying X, Huang Y, Ji W, Qi D. Lv Y, et al. Among authors: ying x. Noncoding RNA Res. 2024 May 16;9(4):1235-1248. doi: 10.1016/j.ncrna.2024.05.004. eCollection 2024 Dec. Noncoding RNA Res. 2024. PMID: 39036604 Free PMC article.

8

N⁶-methyladenosine modification of ITGA6 mRNA promotes the development and progression of bladder cancer.

Jin H, Ying X, Que B, Wang X, Chao Y, Zhang H, Yuan Z, Qi D, Lin S, Min W, Yang M, Ji W. Jin H, et al. Among authors: ying x. EBioMedicine. 2019 Sep;47:195-207. doi: 10.1016/j.ebiom.2019.07.068. Epub 2019 Aug 10. EBioMedicine. 2019. PMID: 31409574 Free PMC article.

9

A Novel tsRNA, m⁷G-3' tiRNA Lys^TTT, Promotes Bladder Cancer Malignancy Via Regulating ANXA2 Phosphorylation.

Ying X, Hu W, Huang Y, Lv Y, Ji D, Chen C, Yang B, Zhang C, Liang Y, Zhang H, Liu M, Yuan G, Wu W, Ji W. Ying X, et al. Adv Sci (Weinh). 2024 Aug;11(31):e2400115. doi: 10.1002/advs.202400115. Epub 2024 Jun 18. Adv Sci (Weinh). 2024. PMID: 38894581 Free PMC article.

10

Integrated analysis of mRNA-m⁶A-protein profiles reveals novel insights into the mechanisms for cadmium-induced urothelial transformation.

Wu B, Jiang X, Huang Y, Ying X, Zhang H, Liu B, Li Z, Qi D, Ji W, Cai X. Wu B, et al. Among authors: ying x. Biomarkers. 2021 Sep;26(6):499-507. doi: 10.1080/1354750X.2021.1913513. Epub 2021 Jun 4. Biomarkers. 2021. PMID: 33830842

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

1,344 results

Search Page

Filters